(Q36609893)

English

HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?

scientific article published on 30 January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management? (English)

1 reference

Europe PubMed Central

15 August 2017

Xavier Sastre-Garau

object named as

X Sastre-Garau

11

0 references

Anne Vincent-Salomon

1

object named as

A Vincent-Salomon

1 reference

Europe PubMed Central

15 August 2017

author name string

J-Y Pierga

2

1 reference

Europe PubMed Central

15 August 2017

J Couturier

3

1 reference

Europe PubMed Central

15 August 2017

C D d'Enghien

4

1 reference

Europe PubMed Central

15 August 2017

C Nos

5

1 reference

Europe PubMed Central

15 August 2017

B Sigal-Zafrani

6

1 reference

Europe PubMed Central

15 August 2017

M Lae

7

1 reference

Europe PubMed Central

15 August 2017

P Fréneaux

8

1 reference

Europe PubMed Central

15 August 2017

V Diéras

9

1 reference

Europe PubMed Central

15 August 2017

J-P Thiéry

10

1 reference

Europe PubMed Central

15 August 2017

language of work or name

0 references

publication date

30 January 2007

1 reference

Europe PubMed Central

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

15 August 2017

96

1 reference

Europe PubMed Central

15 August 2017

654-659

1 reference

Europe PubMed Central

15 August 2017

4

1 reference

Europe PubMed Central

15 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603584

0 references

Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

30 September 2017

Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

30 September 2017

Genomic and expression profiling of chromosome 17 in breast cancer reveals complex patterns of alterations and novel candidate genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

30 September 2017

HER-2 gene amplification can be acquired as breast cancer progresses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

30 September 2017

HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

30 September 2017

Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

30 September 2017

Gene expression profiles of primary breast tumors maintained in distant metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

30 September 2017

From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

30 September 2017

Current perspectives on HER2 testing: a review of national testing guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

30 September 2017

A molecular signature of metastasis in primary solid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

30 September 2017

Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

30 September 2017

Molecular portraits of human breast tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

30 September 2017

Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

30 September 2017

Stability of HER-2/neu expression over time and at multiple metastatic sites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

30 September 2017

An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

30 September 2017

Myofibrosarcoma of the breast: review of the literature on myofibroblastic tumors and criteria for defining myofibroblastic differentiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

30 September 2017

KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

28 June 2018

Amplification of a 280-Kilobase Core Region at the ERBB2 Locus Leads to Activation of Two Hypothetical Proteins in Breast Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

28 June 2018

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

28 June 2018

A pooled analysis of bone marrow micrometastasis in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

20 September 2018

The prognostic value of isolated tumor cells in bone marrow in breast cancer patients: evaluation of morphological categories and the number of clinically significant cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360046

20 September 2018

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17262082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17262082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic relevance of gene amplifications and coamplifications in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17262082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17262082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17262082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17262082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of Her-2/neu overexpression in primary breast cancers and their metastatic lesions: an immunohistochemical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17262082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17262082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17262082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17262082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER2 status in patients with breast carcinoma is not modified selectively by preoperative chemotherapy and is stable during the metastatic process

1 reference

https://pubmed.ncbi.nlm.nih.gov/17262082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

1 reference

https://pubmed.ncbi.nlm.nih.gov/17262082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CCND1- and ERBB2-gene deregulation and PTEN mutation analyses in invasive lobular carcinoma of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/17262082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Re: HER2 Testing in the Real World

1 reference

https://pubmed.ncbi.nlm.nih.gov/17262082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6603584

1 reference

Europe PubMed Central

15 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36609893&oldid=1725132742"